Ethic Inc’s Acceleron Pharma XLRN Stock Holding History

Ethic Inc’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,785	Closed	-$651K	–	699
2021 Q3	$651K	Buy	3,785 +570	+18%	+$74.6K	0.07%	302
2021 Q2	$403K	Buy	3,215 +1,403	+77%	+$177K	0.05%	392
2021 Q1	$246K	Buy	+1,812	New	+$234K	0.04%	427

Ethic Inc's XLRN Position: Q4 2021 in Review

Ethic Inc sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 3,785 shares — an estimated $651K sold.

Ethic Inc first reported a position in XLRN in Q1 2021 and held it in 3 quarters. The position peaked at $651K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Ethic Inc reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Ethic Inc sold 3,785 Acceleron Pharma shares in Q4 2021, an estimated $651K.
Ethic Inc first reported a position in Acceleron Pharma in Q1 2021 and held it in 3 quarters.
Ethic Inc's Acceleron Pharma position peaked at $651K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Ethic Inc's 13F filing for Q4 2021, filed 14 Feb 2022.